Fate Therapeutics
FATE
#7524
Rank
NZ$0.46 B
Marketcap
$4.05
Share price
-5.10%
Change (1 day)
15.69%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$3.60

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.63. In 2022 the company made an earnings per share (EPS) of -$4.87 a decrease over its 2021 EPS that were of -$3.73.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.60-25.96%
2022-$4.8730.49%
2021-$3.737.21%
2020-$3.4845.45%
2019-$2.3919.17%
2018-$2.0117.65%
2017-$1.71-3.77%
2016-$1.77-12.4%
2015-$2.02-3.97%
2014-$2.11-2.09%
2013-$2.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$13.10 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.28-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$14.47 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.19 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.28-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA